Medtronic plc — Earnings

Most recent reported period: FY2026 (Q4) (filed for period ending 2026-01-23) · sourced from SEC EDGAR

Next earnings (estimated): Fri, April 24, 2026 10 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2026-01-23$9.02B↑+8.7%$1.14B↓-11.7%16.2%
2025-10-24$8.96B↑+6.6%$1.38B↑+8.1%18.8%
2025-07-25$8.58B↑+8.4%$1.05B↓-0.2%16.8%
2025-04-25$8.93B↑+3.9%$1.06B↑+61.5%16.1%
2025-01-24$8.29B↑+2.5%$1.29B↓-2.1%19.9%
2024-10-25$8.40B↑+5.2%$1.28B↑+40.3%19.0%
2024-07-26$7.92B↑+2.8%$1.05B↑+31.6%16.1%
2024-04-26$8.59B↑+0.5%$654M↓-44.5%12.3%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2026 (Q4)

Revenue
$9.02B
↑+8.7% +$725M YoY
Net Income
$1.14B
↓-11.7% -$151M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 52 quarters

margin trajectory tells the operating-leverage story
Gross Margin↓-7.3pts
62.3%
Operating Margin↓-3.6pts
16.2%
Net Margin↓-2.9pts
12.7%

Go deeper